{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:18:35Z","timestamp":1793035115907,"version":"4.5.0"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Despite the evident progress in neonatal medicine, retinopathy of prematurity (ROP) remains a serious threat to the vision of premature infants, due to a still partial understanding of the mechanisms underlying the development of this disease and the lack of drugs capable of arresting its progression. Although ROP is a multifactorial disease, retinal vascularization is strictly dependent on oxygen concentration. The exposition of the retina of a preterm newborn, still incompletely vascularized, to an atmosphere relatively hyperoxic, as the extrauterine environment, induces the downregulation of proangiogenic factors and therefore the interruption of vascularization (first ischemic phase of ROP). However, over the following weeks, the growing metabolic requirement of this ischemic retina produces a progressive hypoxia that specularly promotes the surge of proangiogenic factors, finally leading to proliferative retinopathy (second proliferative phase of ROP). The demonstration that the noradrenergic system is actively involved in the coupling between hypoxia and the induction of vasculogenesis paved the way for a pharmacologic intervention aimed at counteracting the interaction of noradrenaline with specific receptors and consequently the progression of ROP. A similar trend has been observed in infantile hemangiomas, the most common vascular lesion of childhood induced by pre-existing hypoxia, which shares similar characteristics with ROP. The fact that propranolol, an unselective antagonist of \u03b21\/2 adrenoceptors, counteracts the growth of infantile hemangiomas, suggested the idea of testing the efficacy of propranolol in infants with ROP. From preclinical studies, ongoing clinical trials demonstrated that topical administration of propranolol likely represents the optimal approach to reconcile its efficacy and maximum safety. Given the strict relationship between vessels and neurons, recovering retinal vascularization with propranolol may add further efficacy to prevent retinal dysfunction. In conclusion, the strategy of contrasting precociously the progression of the disease appears to be more advantageous than the current wait-and-see therapeutic approach, which instead is mainly focused on avoiding retinal detachment.<\/jats:p>","DOI":"10.3389\/fped.2024.1322783","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T23:39:33Z","timestamp":1705361973000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression"],"prefix":"10.3389","volume":"12","author":[{"given":"Francesca","family":"Pascarella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Teresa","family":"Scaramuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cammalleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Ciantelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1542\/peds.2007-0803","article-title":"Infantile hemangiomas and retinopathy of prematurity: possible association","volume":"123","author":"Praveen","year":"2009","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00431-013-1966-y","article-title":"Infantile hemangiomas and retinopathy of prematurity: clues to the regulation of vasculogenesis","volume":"172","author":"Hyland","year":"2013","journal-title":"Eur J Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/med.21336","article-title":"Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the \u03b2-adrenergic system","volume":"35","author":"Filippi","year":"2015","journal-title":"Med Res Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1542\/peds.2014-3673","article-title":"Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies","volume":"136","author":"Wassef","year":"2015","journal-title":"Pediatrics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40257-013-0008-x","article-title":"Infantile hemangiomas: an update","volume":"14","author":"Kwon","year":"2013","journal-title":"Am J Clin Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1525-1470.2005.00102.x","article-title":"Infantile hemangiomas: current knowledge, future directions","volume":"22","author":"Frieden","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jpeds.2006.12.003","article-title":"Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics","volume":"150","author":"Haggstrom","year":"2007","journal-title":"J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000521413","article-title":"Association of infantile hemangiomas and retinopathy of prematurity: analysis of the multicenter KID","volume":"7","author":"Dankhara","year":"2022","journal-title":"Biomed Hub"},{"key":"B9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1525-1470.2007.00450.x","article-title":"Placental anomalies in children with infantile hemangioma","volume":"24","author":"L\u00f3pez Guti\u00e9rrez","year":"2007","journal-title":"Pediatr Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/archdermatol.2010.1295","article-title":"Characteristics of infantile hemangiomas as clues to pathogenesis: does hypoxia connect the dots?","volume":"146","author":"Drolet","year":"2010","journal-title":"Arch Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/bjo.87.3.275","article-title":"Retinal neovascular markers in retinopathy of prematurity: aetiological implications","volume":"87","author":"North","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3892\/mmr.2012.1075","article-title":"Regulation of glucose transporter protein-1 and vascular endothelial growth factor by hypoxia inducible factor 1\u03b1 under hypoxic conditions in hep-2 human cells","volume":"6","author":"Xu","year":"2012","journal-title":"Mol Med Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease","volume":"27","author":"Penn","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1167\/iovs.03-0249","article-title":"Reduced retinal angiogenesis in MMP-2-deficient mice","volume":"44","author":"Ohno-Matsui","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cyto.2009.11.012","article-title":"Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanisms of endothelial growth","volume":"49","author":"Przewratil","year":"2010","journal-title":"Cytokine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1542\/peds.2004-1518","article-title":"Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies","volume":"116","author":"Marler","year":"2005","journal-title":"Pediatrics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1161\/ATVBAHA.107.150284","article-title":"Hypoxia-induced mediators of stem\/progenitor cell trafficking are increased in children with hemangioma","volume":"27","author":"Kleinman","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B18","volume-title":"Epidemiology for Health Promotion and Disease Prevention Professionals","author":"Miller","year":"2002"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.4103\/jfmpc.jfmpc","article-title":"Retinopathy of prematurity: addressing the emerging burden in developing countries","volume":"9","author":"Senjam","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"12487","DOI":"10.3390\/ijms241512487","article-title":"Fetal oxygenation from the 23rd to the 36th week of gestation evaluated through the umbilical cord blood gas analysis","volume":"24","author":"Filippi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/70963","article-title":"Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor","volume":"5","author":"Smith","year":"1999","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2431-10-83","article-title":"Study protocol: safety and efficacy of propranolol in newborns with retinopathy of prematurity (PROP-ROP): iSRCTN18523491","volume":"10","author":"Filippi","year":"2010","journal-title":"BMC Pediatr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/archophthalmol.2011.319","article-title":"Neonatal bacteremia and retinopathy of prematurity: the ELGAN study","volume":"129","author":"Tolsma","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1055\/s-0041-1733785","article-title":"Association of surgical necrotizing enterocolitis and its timing with retinopathy of prematurity","volume":"40","author":"Fundora","year":"2023","journal-title":"Am J Perinatol"},{"key":"B25","first-page":"1217","article-title":"Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis","volume":"41","author":"Hughes","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/aos.12049","article-title":"The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge","volume":"92","author":"Cavallaro","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e5514","DOI":"10.1371\/journal.pone.0005514","article-title":"O2 level controls hematopoietic circulating progenitor cells differentiation into endothelial or smooth muscle cells","volume":"4","author":"Berthelemy","year":"2009","journal-title":"PLoS One"},{"key":"B28","first-page":"2367","article-title":"Development of astrocytes and their relation to blood vessels in fetal monkey retina","volume":"37","author":"Gariano","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B29","first-page":"3442","article-title":"Vascular development in primate retina: comparison of laminar plexus formation in monkey and human","volume":"35","author":"Gariano","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1140021","DOI":"10.3389\/fped.2023.1140021","article-title":"Fetal oxygenation in the last weeks of pregnancy evaluated through the umbilical cord blood gas analysis","volume":"11","author":"Filippi","year":"2023","journal-title":"Front Pediatr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.001","article-title":"Retinal vasculature development in health and disease","volume":"63","author":"Selvam","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1001\/jama.2018.5725","article-title":"Association between oxygen saturation targeting and death or disability in extremely preterm infants in the neonatal oxygenation prospective meta-analysis collaboration","volume":"319","author":"Askie","year":"2018","journal-title":"JAMA"},{"key":"B33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0040-1713181","article-title":"Update in the treatment of retinopathy of prematurity","volume":"39","author":"Bancalari","year":"2022","journal-title":"Am J Perinatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.preteyeres.2008.09.003","article-title":"Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management","volume":"27","author":"Kaur","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1136\/bjo.2007.135640","article-title":"VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (lucentis) in microvascular retinal endothelial cells","volume":"92","author":"Deissler","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"835771","DOI":"10.3389\/fphar.2022.835771","article-title":"Decoupling oxygen tension from retinal vascularization as a new perspective for management of retinopathy of prematurity. New opportunities from \u03b2-adrenoceptors","volume":"13","author":"Filippi","year":"2022","journal-title":"Front Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3390\/biomedicines1007160","article-title":"Neurosensory alterations in retinopathy of prematurity: a window to neurological impairments associated to preterm birth","volume":"10","author":"Lucchesi","year":"2022","journal-title":"Biomedicines"},{"key":"B38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1053\/j.semperi.2019.05.012","article-title":"Retinopathy of prematurity, visual and neurodevelopmental outcome, and imaging of the central nervous system","volume":"43","author":"Morken","year":"2019","journal-title":"Semin Perinatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"816409","DOI":"10.3389\/fped.2022.81640","article-title":"Severe retinopathy of prematurity associated with neurodevelopmental disorder in children","volume":"10","author":"Choi","year":"2022","journal-title":"Front Pediatr"},{"key":"B40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1017\/S2040174411000766","article-title":"Developmental outcome in preterm infants <29 weeks gestation with \u2264stage 3 retinopathy of prematurity (ROP): relationship to severity of ROP","volume":"3","author":"Todd","year":"2012","journal-title":"J Dev Orig Health Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.earlhumdev.2006.02.011","article-title":"Eye-hand co-ordination skills in very preterm infants <29 weeks gestation at 3 years: effects of preterm birth and retinopathy of prematurity","volume":"82","author":"Goyen","year":"2006","journal-title":"Early Hum Dev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.oret.2020.02.001","article-title":"Reactivation of retinopathy of prematurity in adults and adolescents","volume":"4","author":"Uner","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"B43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/EB.S95021","article-title":"Retinal, visual, and refractive development in retinopathy of prematurity","volume":"8","author":"Moskowitz","year":"2016","journal-title":"Eye Brain"},{"key":"B44","doi-asserted-by":"publisher","first-page":"100878","DOI":"10.1016\/j.preteyeres.2020.100878","article-title":"Plexus-specific retinal vascular anatomy and pathologies as seen by projection-resolved optical coherence tomographic angiography","volume":"80","author":"Hormel","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1542\/peds.2006-0385","article-title":"The retina as a window to the brain in vulnerable neonates","volume":"117","author":"Msall","year":"2006","journal-title":"Pediatrics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e0230678","DOI":"10.1371\/journal.pone.0230678","article-title":"Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity","volume":"15","author":"Arima","year":"2020","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"F532","DOI":"10.1136\/archdischild-2016-312533","article-title":"Severe retinopathy of prematurity predicts delayed white matter maturation and poorer neurodevelopment","volume":"102","author":"Glass","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B48","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1136\/archdischild-2016-310532","article-title":"Epidemiology of blindness in children","volume":"102","author":"Solebo","year":"2017","journal-title":"Arch Dis Child"},{"key":"B49","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.clp.2013.02.001","article-title":"Retinopathy of prematurity-incidence today","volume":"40","author":"Zin","year":"2013","journal-title":"Clin Perinatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum Dev"},{"key":"B51","doi-asserted-by":"publisher","first-page":"xxviii","DOI":"10.1016\/j.ajo.2018.05.024","article-title":"Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline Lens: I. Preliminary report","volume":"192","author":"Terry","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"B52","first-page":"262","article-title":"Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II. Report of cases-clinical aspects","volume":"1942","author":"Terry","year":"1942","journal-title":"Trans Am Ophthalmol Soc"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1542\/peds.2004-1180","article-title":"Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs","volume":"115","author":"Gilbert","year":"2005","journal-title":"Pediatrics"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/0895-4356(92)90168-m","article-title":"Oxygen as a cause of blindness in premature infants: \u201cautopsy\u201d of a decade of errors in clinical epidemiologic research","volume":"45","author":"Jacobson","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1542\/peds.86.3.405","article-title":"Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic","volume":"86","author":"Gibson","year":"1990","journal-title":"Pediatrics"},{"key":"B56","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1542\/peds.67.6.924","article-title":"Retinopathy of prematurity: an estimate of vision loss in the United States\u20131979","volume":"67","author":"Phelps","year":"1981","journal-title":"Pediatrics"},{"key":"B57","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3345\/cep.2021.00773","article-title":"Retinopathy of prematurity: a review of epidemiology and current treatment strategies","volume":"65","author":"Hong","year":"2022","journal-title":"Clin Exp Pediatr"},{"key":"B58","doi-asserted-by":"publisher","first-page":"717","DOI":"10.4103\/ijo.IJO_496_19","article-title":"The changing scenario of retinopathy of prematurity in middle and low income countries: unique solutions for unique problems","volume":"67","author":"Vinekar","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"key":"B60","first-page":"S89","article-title":"Update on blindness due to retinopathy of prematurity globally and in India","volume":"53","author":"Blencowe","year":"2016","journal-title":"Indian Pediatr"},{"key":"B61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1542\/peds.2004-1413","article-title":"The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study","volume":"116","author":"Good","year":"2005","journal-title":"Pediatrics"},{"key":"B62","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","article-title":"Retinopathy of prematurity: a review of risk factors and their clinical significance","volume":"63","author":"Kim","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4103\/0301-4738.33817","article-title":"Retinopathy of prematurity in Asian Indian babies weighing greater than 1250 grams at birth: ten year data from a tertiary care center in a developing country","volume":"55","author":"Vinekar","year":"2007","journal-title":"Indian J Ophthalmol"},{"key":"B64","first-page":"S80","article-title":"Can we stop the current epidemic of blindness from retinopathy of prematurity?","volume":"53","author":"Dutta","year":"2016","journal-title":"Indian Pediatr"},{"key":"B65","volume-title":"Park\u2019s Textbook of Preventive and Social Medicine","author":"Park","year":"2021"},{"key":"B66","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jaapos.2009.10.011","article-title":"Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity","volume":"14","author":"Law","year":"2010","journal-title":"J AAPOS"},{"key":"B67","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1053\/j.semperi.2019.05.011","article-title":"Anti-vascular endothelial growth factor intravitreal therapy for retinopathy of prematurity","volume":"43","author":"VanderVeen","year":"2019","journal-title":"Semin Perinatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/pch\/21.2.101","article-title":"Retinopathy of prematurity: an update on screening and management","volume":"21","author":"Jefferies","year":"2016","journal-title":"Paediatr Child Health"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1001\/archopht.1994.01090140028007","article-title":"Laser therapy for retinopathy of prematurity","volume":"112","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"160","DOI":"10.5546\/aap.2014.eng.160","article-title":"Intravitreal bevacizumab as single drug therapy for retinopathy of prematurity in 12 patients","volume":"112","author":"Bancalari","year":"2014","journal-title":"Arch Argent Pediatr"},{"key":"B73","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/02713683.2016.1196709","article-title":"Comparison of bevacizumab, ranibizumab, and laser photocoagulation in the treatment of retinopathy of prematurity in Turkey","volume":"42","author":"Gunay","year":"2017","journal-title":"Curr Eye Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1080\/02713683.2016.1264607","article-title":"Comparison of intravitreal bevacizumab, intravitreal ranibizumab and laser photocoagulation for treatment of type 1 retinopathy of prematurity in Turkish preterm children","volume":"42","author":"Kabata\u015f","year":"2017","journal-title":"Curr Eye Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.ophtha.2020.12.028","article-title":"Retinal detachment after treatment of retinopathy of prematurity with laser vs. intravitreal anti-vascular endothelial growth factor","volume":"128","author":"Barry","year":"2021","journal-title":"Ophthalmology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e20153218","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"key":"B77","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jaapos.2017.10.006","article-title":"Group, medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity","volume":"22","author":"Kennedy","year":"2018","journal-title":"J AAPOS"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma","volume":"372","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","journal-title":"N Engl J Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000510029","article-title":"The efficacy and safety of topical \u03b2-blockers in treating infantile hemangiomas: a meta-analysis including 11 randomized controlled trials","volume":"237","author":"Wang","year":"2021","journal-title":"Dermatology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1152\/ajpregu.1998.274.1.R19","article-title":"CO2 asphyxia increases plasma norepinephrine in rats via sympathetic nerves","volume":"274","author":"Borovsky","year":"1998","journal-title":"Am J Physiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1002\/ijc.25589","article-title":"Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1\u03b1 protein-dependent mechanism","volume":"128","author":"Park","year":"2011","journal-title":"Int J Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1167\/iovs.10-5536","article-title":"Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade","volume":"52","author":"Ristori","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B84","doi-asserted-by":"publisher","first-page":"20681","DOI":"10.1074\/jbc.M300368200","article-title":"Beta 3-adrenergic receptors regulate retinal endothelial cell migration and proliferation J","volume":"278","author":"Steinle","year":"2003","journal-title":"Biol Chem"},{"key":"B85","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1161\/HYPERTENSIONAHA.111.189605","article-title":"Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo","volume":"60","author":"Sorriento","year":"2012","journal-title":"Hypertension"},{"key":"B86","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.3390\/ijms23095140","article-title":"Is infantile hemangioma a neuroendocrine tumor?","volume":"23","author":"Kaulanjan-Checkmodine","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1167\/iovs.10-5176","article-title":"The mouse retina as an angiogenesis model","volume":"51","author":"Stahl","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0076-6879(08)02806-1","article-title":"Chapter 6. Ocular models of angiogenesis","volume":"444","author":"Aguilar","year":"2008","journal-title":"Methods Enzymol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"106713","DOI":"10.1016\/j.phrs.2023.106713","article-title":"The \u03b23 adrenoceptor in proliferative retinopathies: \u201cCinderella\u201d steps out of its family shadow","volume":"190","author":"Cammalleri","year":"2023","journal-title":"Pharmacol Res"},{"key":"B90","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"Alon","year":"1995","journal-title":"Nat Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat Protoc"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1471-4159.2011.07530.x","article-title":"Antiangiogenic effects of \u03b22 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy","volume":"119","author":"Martini","year":"2011","journal-title":"J Neurochem"},{"key":"B94","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exer.2013.03.013","article-title":"Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice","volume":"111","author":"Dal Monte","year":"2013","journal-title":"Exp Eye Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/pr.2014.108","article-title":"Pharmacokinetics and local safety profile of propranolol eye drops in rabbits","volume":"76","author":"Padrini","year":"2014","journal-title":"Pediatr Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fncel.2017.00395","article-title":"The beta adrenergic receptor blocker propranolol counteracts retinal dysfunction in a mouse model of oxygen induced retinopathy: restoring the balance between apoptosis and autophagy","volume":"11","author":"Cammalleri","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1089\/jop.2020.0092","article-title":"Ocular versus oral propranolol for prevention and\/or treatment of oxygen-induced retinopathy in a rat model","volume":"37","author":"Qadri","year":"2021","journal-title":"J Ocul Pharmacol Ther"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.jpeds.2013.07.049","article-title":"Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives","volume":"163","author":"Filippi","year":"2013","journal-title":"J Pediatr"},{"key":"B99","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1515\/jpm-2015-0357","article-title":"Oral propranolol in early stages of retinopathy of prematurity","volume":"44","author":"Bancalari","year":"2016","journal-title":"J Perinat Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/archdischild-2013-303951","article-title":"Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study","volume":"98","author":"Makhoul","year":"2013","journal-title":"Arch Dis Child"},{"key":"B101","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/02713683.2016.1158272","article-title":"The efficacy of propranolol in retinopathy of prematurity and its correlation with the platelet mass Index","volume":"42","author":"Korkmaz","year":"2017","journal-title":"Curr Eye Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"F389","DOI":"10.1136\/archdischild-2016-311548","article-title":"Prophylactic propranolol for prevention of ROP and visual outcome at 1 year (PreROP trial)","volume":"102","author":"Sanghvi","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B103","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3760\/cma.j.issn.2096-2932.2018.04.007","article-title":"The efficacy and safety of oral propranolol in the treatment of retinopathy of prematurity","volume":"33","author":"Sun","year":"2018","journal-title":"Chin J Neonatol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s10792-018-1018-8","article-title":"The efficacy of propranolol in very preterm infants at the risk of retinopathy of prematurity: which newborn and when?","volume":"39","author":"Ozturk","year":"2019","journal-title":"Int Ophthalmol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22038\/IJN.2023.70115.2361","article-title":"Efficacy of oral propranolol in prevention of severe retinopathy of prematurity: a randomized clinical trial study","volume":"14","author":"Mohammadi","year":"2023","journal-title":"Iran J Neonat"},{"key":"B106","doi-asserted-by":"publisher","first-page":"56","DOI":"10.34172\/cjmb.2022.10","article-title":"Efficacy of oral propranolol on the treatment of retinopathy of prematurity","volume":"9","author":"Hosseini","year":"2022","journal-title":"CJMB"},{"key":"B107","doi-asserted-by":"publisher","first-page":"CD011893","DOI":"10.1002\/14651858.CD011893.pub2","article-title":"Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants","volume":"3","author":"Kaempfen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41372-019-0503-x","article-title":"Oral propranolol in prevention of severe retinopathy of prematurity: a systematic review and meta-analysis","volume":"39","author":"Stritzke","year":"2019","journal-title":"J Perinatol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"631673","DOI":"10.3389\/fped.2021.631673","article-title":"Clinical efficacy and safety of propranolol in the prevention and treatment of retinopathy of prematurity: a meta-analysis of randomized controlled trials","volume":"9","author":"Kong","year":"2021","journal-title":"Front Pediatr"},{"key":"B110","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajo.2023.11.012","article-title":"Effectiveness of propranolol in preventing severe retinopathy of prematurity: a comprehensive systematic review and meta-analysis","volume":"259","author":"Shafique","year":"2023","journal-title":"Am J Ophthalmol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/pr.2016.230","article-title":"Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial","volume":"81","author":"Filippi","year":"2017","journal-title":"Pediatr Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fped.2019.00180","article-title":"Propranolol 0.2% eye micro-drops for retinopathy of prematurity: a prospective phase IIB study","volume":"7","author":"Filippi","year":"2019","journal-title":"Front Pediatr"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/apa.16850","article-title":"Treating infants with 0.2% propranolol eye micro-drops drastically reduced the progression of retinopathy of prematurity","volume":"112","author":"Scaramuzzo","year":"2023","journal-title":"Acta Paediatr"},{"key":"B114","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3389\/fped.2019.00479","article-title":"Refractive outcome in preterm newborns with ROP after propranolol treatment. A retrospective observational cohort study","volume":"7","author":"Filippi","year":"2019","journal-title":"Front Pediatr"},{"key":"B115","first-page":"3809","article-title":"Propranolol enhanced adipogenesis instead of induction of apoptosis of hemangiomas stem cells","volume":"7","author":"Ma","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1747-1028-8-1","article-title":"The role of \u03b2-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cells","volume":"8","author":"Ji","year":"2013","journal-title":"Cell Div"},{"key":"B117","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/SLA.0b013e318254ce7a","article-title":"Propranolol induces regression of hemangioma cells through HIF-1\u03b1-mediated inhibition of VEGF-A","volume":"256","author":"Chim","year":"2012","journal-title":"Ann Surg"},{"key":"B118","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/archopht.130.1.117","article-title":"\u03b2-blocking and racial variation in the severity of retinopathy of prematurity","volume":"130","author":"Good","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nm1750","article-title":"A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure","volume":"14","author":"Liggett","year":"2008","journal-title":"Nat Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e43026","DOI":"10.7554\/eLife.43026","article-title":"R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma","volume":"8","author":"Overman","year":"2019","journal-title":"Elife"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e151109","DOI":"10.1172\/JCI151109","article-title":"Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma","volume":"132","author":"Seebauer","year":"2022","journal-title":"J Clin Invest"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/PRS.0b013e318267d3db","article-title":"Propranolol accelerates adipogenesis in hemangioma stem cells and causes apoptosis of hemangioma endothelial cells","volume":"130","author":"Wong","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1097\/SAP.0000000000002104","article-title":"Propranolol accelerats hemangioma stem cell transformation into adipocyte","volume":"83","author":"Li","year":"2019","journal-title":"Ann Plast Surg"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1322783\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T23:39:42Z","timestamp":1705361982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1322783\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":123,"alternative-id":["10.3389\/fped.2024.1322783"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1322783","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"article-number":"1322783"}}